A pharmacological exploration of targeted drug therapy in non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-022-01744-6.pdf
Reference100 articles.
1. Cancer n.d. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 2 Oct 2021.
2. Malik PS, Raina V. Lung cancer: prevalent trends & emerging concepts. Indian J Med Res Suppl. 2015;141:5–7. https://doi.org/10.4103/0971-5916.154479.
3. Types of Lung Cancer: Common, Rare and More Varieties | CTCA n.d. https://www.cancercenter.com/cancer-types/lung-cancer/types. Accessed 7 Nov 2021
4. Raut NV, Srivastava S, Gangwani GD, Ali HS. A case report of primary resistance to EGFR TKI in lung adenocarcinoma due to coexisting MET Exon 14 skipping mutation with excellent response to combination of Gefitinib and Capmatinib. Indian J Med Paediatr Oncol. 2021;42:204–7. https://doi.org/10.1055/s-0041-1731851.
5. Treating Non-Small Cell Lung Cancer n.d.:1–46. https://www.cancer.org/cancer/lung-cancer/treating-non-small-cell.html
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions;Cancers;2024-01-11
2. Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy;ACS Omega;2023-05-24
3. The role of immunotherapy in lung cancer: Actual scenery;European Journal of Life Sciences;2023-04-24
4. Long noncoding RNA POU6F2-AS2 contributes to the aggressiveness of nonsmall-cell lung cancer via microRNA-125b-5p-mediated E2F3 upregulation;Aging;2023-04-06
5. Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action;International Journal of Molecular Sciences;2023-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3